Greetje Groenendaal1, 2, Alie Borren2, Maaike Moman2, Evelyn Monninkhof3, Paul van Diest4, Marille Philippens2, Marco van Vulpen2, Uulke van der Heide1,<sup
1Radiotherapy, NKI-AVL, Amsterdam, Netherlands; 2Radiotherapy, UMC Utrecht, Utrecht, Netherlands; 3Julius Centre, UMC Utrecht, Utrecht, Netherlands; 4Pathology, UMC Utrecht, Utrecht, Netherlands
For the purpose of focal boost radiotherapy a voxel-wise tumor prediction model was developed for the prostate peripheral zone (PZ) using diffusion weighted imaging and dynamic contrast-enhanced MRI. This model showed an area under the receiver operating curve of 0.89 on a voxel level when validated with whole-mount section histopathology. The voxel size used was 2.5x2.5x2.5 mm3 The model output can be used to define different risk levels for tumor presence, which in turn could serve as an input for dose planning. In this way the robustness of tumor delineations for focal boost therapy can be greatly improved.